They better not consider a buy out! Sure, the big pharma of America will want to get their fingers in the pie, but if needs be, Recce can open an office and list over there as a subsidiary. Would probably be handy for them to have sales offices in every first world country anyway. I would be voting against any take over. Surely they wouldn't consider it? Australian Govt might even block it considering foreign investment rules?
RCE Price at posting:
$1.26 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)